Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Durogesic DTrans 25micrograms/hour transdermal patches
0407020A0BBAIAE
|
Durogesic | Fentanyl | Central Nervous System | 6,724 |
|
Durogesic DTrans 12micrograms/hour transdermal patches
0407020A0BBAMAU
|
Durogesic | Fentanyl | Central Nervous System | 5,369 |
|
Durogesic DTrans 50micrograms/hour transdermal patches
0407020A0BBAJAF
|
Durogesic | Fentanyl | Central Nervous System | 4,679 |
|
Durogesic DTrans 100micrograms/hour transdermal patches
0407020A0BBALAH
|
Durogesic | Fentanyl | Central Nervous System | 3,293 |
|
Durogesic DTrans 75micrograms/hour transdermal patches
0407020A0BBAKAG
|
Durogesic | Fentanyl | Central Nervous System | 2,706 |
|
Durogesic 100micrograms transdermal patches
0407020A0BBADAH
|
Durogesic | Fentanyl | Central Nervous System | No data available |
|
Durogesic 25micrograms transdermal patches
0407020A0BBAAAE
|
Durogesic | Fentanyl | Central Nervous System | No data available |
|
Durogesic 50micrograms transdermal patches
0407020A0BBABAF
|
Durogesic | Fentanyl | Central Nervous System | No data available |
|
Durogesic 75micrograms transdermal patches
0407020A0BBACAG
|
Durogesic | Fentanyl | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.